Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AngioCloud Service

K-Number: K211713 · 2022-04-28

ApplicantAngiocloud, LLC
Decision Date2022-04-28
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

AngioCloud Service is a medical device manufactured by Angiocloud, LLC. It received FDA 510(k) clearance on 2022-04-28 under approval number K211713. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AngioCloud Service?

AngioCloud Service is a medical device that received FDA 510(k) clearance on 2022-04-28. It is manufactured by Angiocloud, LLC. The 510(k) number is K211713.

When was AngioCloud Service approved by the FDA?

AngioCloud Service received FDA 510(k) clearance on 2022-04-28, under approval number K211713.

What company makes AngioCloud Service?

AngioCloud Service is manufactured by Angiocloud, LLC.

What is the FDA product code for AngioCloud Service?

The FDA product code for AngioCloud Service is LLZ.

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑